Aurore Daron

1.2k total citations
16 papers, 189 citations indexed

About

Aurore Daron is a scholar working on Molecular Biology, Genetics and Surgery. According to data from OpenAlex, Aurore Daron has authored 16 papers receiving a total of 189 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 10 papers in Genetics and 4 papers in Surgery. Recurrent topics in Aurore Daron's work include Neurogenetic and Muscular Disorders Research (10 papers), RNA modifications and cancer (7 papers) and Muscle Physiology and Disorders (4 papers). Aurore Daron is often cited by papers focused on Neurogenetic and Muscular Disorders Research (10 papers), RNA modifications and cancer (7 papers) and Muscle Physiology and Disorders (4 papers). Aurore Daron collaborates with scholars based in Belgium, France and United Kingdom. Aurore Daron's co-authors include Laurent Servais, Mariacristina Scoto, Teresa Gidaro, M. Annoussamy, Nicolas Deconinck, Claude Cancés, Juliette Ropars, Inge Cuppen, Imelda Hughes and Chiara Marini‐Bettolo and has published in prestigious journals such as Neurology, Developmental Medicine & Child Neurology and Cephalalgia.

In The Last Decade

Aurore Daron

15 papers receiving 185 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Aurore Daron Belgium	6	154	132	112	21	13	16	189
Maria Mazurkiewicz-Bełdzińska Poland	5	203 1.3×	138 1.0×	115 1.0×	25 1.2×	12 0.9×	17	225
Nur Imma Fatimah Harahap Japan	9	213 1.4×	193 1.5×	86 0.8×	17 0.8×	26 2.0×	32	267
Jena M. Krueger United States	6	153 1.0×	127 1.0×	99 0.9×	24 1.1×	46 3.5×	13	228
ST Iannaccone United States	4	277 1.8×	220 1.7×	130 1.2×	15 0.7×	24 1.8×	10	306
Adrian Tassoni Germany	6	81 0.5×	68 0.5×	72 0.6×	15 0.7×	15 1.2×	10	158
Maryjane Benton United States	4	121 0.8×	90 0.7×	70 0.6×	8 0.4×	16 1.2×	5	167
Astrid Pechmann Germany	3	127 0.8×	84 0.6×	87 0.8×	16 0.8×	9 0.7×	8	161
Stephanie Fradette United States	4	172 1.1×	140 1.1×	91 0.8×	7 0.3×	10 0.8×	15	203
Ai Sakonju United States	4	144 0.9×	95 0.7×	103 0.9×	25 1.2×	23 1.8×	8	203
Giulia Norcia Italy	8	72 0.5×	65 0.5×	51 0.5×	22 1.0×	3 0.2×	10	126

Countries citing papers authored by Aurore Daron

Since Specialization

Citations

This map shows the geographic impact of Aurore Daron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aurore Daron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aurore Daron more than expected).

Fields of papers citing papers by Aurore Daron

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aurore Daron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aurore Daron. The network helps show where Aurore Daron may publish in the future.

Co-authorship network of co-authors of Aurore Daron

This figure shows the co-authorship network connecting the top 25 collaborators of Aurore Daron. A scholar is included among the top collaborators of Aurore Daron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aurore Daron. Aurore Daron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Daron, Aurore, et al.. (2023). Case report of cerebral cystic echinococcosis in a 5-year-old child. Frontiers in Tropical Diseases. 4.

Dangouloff, Tamara, Praveen Thokala, Matt Stevenson, et al.. (2023). Cost-effectiveness of spinal muscular atrophy newborn screening based on real-world data in Belgium. Neuromuscular Disorders. 34. 61–67. 11 indexed citations

Rippert, Pascal, et al.. (2022). Scoring People With Spinal Muscular Atrophy on the Motor Function Measure Using the Microsoft Kinect. Pediatric Physical Therapy. 35(1). 36–41. 1 indexed citations

Daron, Aurore, O. Schneider, Fabian Dal Farra, et al.. (2021). Normative data on spontaneous stride velocity, stride length, and walking activity in a non-controlled environment. Orphanet Journal of Rare Diseases. 16(1). 318–318. 14 indexed citations

Servais, Laurent, Giovanni Baranello, Mariacristina Scoto, Aurore Daron, & Maryam Oskoui. (2021). Therapeutic interventions for spinal muscular atrophy: preclinical and early clinical development opportunities. Expert Opinion on Investigational Drugs. 30(5). 519–527. 19 indexed citations

Daron, Aurore, O. Schneider, Fabian Dal Farra, et al.. (2021). DMD/BMD – OUTCOME MEASURES. Neuromuscular Disorders. 31. S86–S87. 1 indexed citations

Daron, Aurore, et al.. (2019). Sitting in patients with spinal muscular atrophy type 1 treated with nusinersen. Developmental Medicine & Child Neurology. 62(3). 310–314. 38 indexed citations

Servais, Laurent, et al.. (2019). P.191Maximal stride velocity detects positive and negative changes over 6- month-time period in ambulant patients with Duchenne muscular dystrophy. Neuromuscular Disorders. 29. S105–S105. 4 indexed citations

Daron, Aurore, Stéphanie Delstanche, Tamara Dangouloff, & Laurent Servais. (2019). [Infantile spinal muscular atrophy : therapeutic (R)evolution].. PubMed. 74(2). 82–85. 1 indexed citations

10.

Daron, Aurore, Carole Vuillerot, Claude Cancés, et al.. (2018). Nusinersen in patients older than 7 months with spinal muscular atrophy type 1. Neurology. 91(14). e1312–e1318. 86 indexed citations

11.

Seferian, A., A. Moraux, Teresa Gidaro, et al.. (2017). Innovative home activity monitoring in non-ambulant patients with spinal muscular atrophy: a multicenter observational trial. Neuromuscular Disorders. 27. S225–S225. 1 indexed citations

12.

Seferian, Andrei, Teresa Gidaro, C. Lilien, et al.. (2017). First experience of Nusinersen early access program in patients with spinal muscular atrophy type 1. Neuromuscular Disorders. 27. S211–S212. 1 indexed citations

13.

Chabanon, A., M. Annoussamy, Aurore Daron, et al.. (2017). Longitudinal data of the European prospective natural history study of patients with type 2 and 3 spinal muscular atrophy. Neuromuscular Disorders. 27. S134–S134. 3 indexed citations

14.

Chabanon, A., Yann Péréon, Aurore Daron, et al.. (2016). Baseline data from a European prospective and longitudinal natural history study of patients with type 2 and 3 spinal muscular atrophy – NatHis-SMA. Neuromuscular Disorders. 26. S103–S103. 2 indexed citations

15.

Annoussamy, M., C. Lilien, Teresa Gidaro, et al.. (2016). Baseline data from patients with myotubular myopathy enrolled in a European prospective and longitudinal natural history study. Neuromuscular Disorders. 26. S116–S117. 1 indexed citations

16.

Magis, Delphine, Elles M. J. Boon, Gianluca Coppola, Aurore Daron, & Jean Schoenen. (2012). A novel CACNA1A mutation results in episodic ataxia with migrainous features without headache. Cephalalgia. 32(15). 1147–1149. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact